Sep 22, 2026 7 0
Uploaded by Quinn
Favorite
Share
More Options
17
Preclinical Evaluation of AZD6422 - an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancers_Page 1

Open in WPS to view all 17 pages